{"count": 16, "results": [{"_id": "32162316", "pmid": 32162316, "title": "The effect of metformin on the risk of recurrent nonmelanoma skin cancers.", "journal": "Int J Dermatol", "authors": ["Ravishankar A", "Zhang T", "Lindgren BR", "Farah RS", "Dong Z", "Goldfarb NI"], "date": "2020-08-01T00:00:00Z", "doi": "10.1111/ijd.14829", "meta_date_publication": "2020 Aug", "meta_volume": "59", "meta_issue": "8", "meta_pages": "e303-e305", "score": 50275.062, "text_hl": "The effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the risk of recurrent @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@nonmelanoma skin cancers@@@.", "citations": {"NLM": "Ravishankar A, Zhang T, Lindgren BR, Farah RS, Dong Z, Goldfarb NI. The effect of metformin on the risk of recurrent nonmelanoma skin cancers. Int J Dermatol. 2020 Aug;59(8):e303-e305. PMID: 32162316", "BibTeX": "@article{32162316, title={The effect of metformin on the risk of recurrent nonmelanoma skin cancers.}, author={Ravishankar A and Zhang T and Lindgren BR and Farah RS and Dong Z and Goldfarb NI}, journal={Int J Dermatol}, volume={59}, number={8}, pages={e303-e305}}"}}, {"_id": "35745575", "pmid": 35745575, "pmcid": "PMC9227071", "title": "Formulation and Characterization of Metformin-Loaded Ethosomes for Topical Application to Experimentally Induced Skin Cancer in Mice", "journal": "Pharmaceuticals (Basel)", "authors": ["Mousa IA", "Hammady TM", "Gad S", "Zaitone SA", "El-Sherbiny M", "Sayed OM"], "date": "2022-05-25T00:00:00Z", "doi": "10.3390/ph15060657", "meta_date_publication": "2022 May 25", "meta_volume": "15", "meta_issue": "6", "meta_pages": "", "score": 50274.125, "text_hl": "Formulation and Characterization of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Loaded Ethosomes for Topical Application to Experimentally Induced @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@Skin Cancer@@@ in Mice", "citations": {"NLM": "Mousa IA, Hammady TM, Gad S, Zaitone SA, El-Sherbiny M, Sayed OM. Formulation and Characterization of Metformin-Loaded Ethosomes for Topical Application to Experimentally Induced Skin Cancer in Mice Pharmaceuticals (Basel). 2022 May 25;15(6):. PMID: 35745575", "BibTeX": "@article{35745575, title={Formulation and Characterization of Metformin-Loaded Ethosomes for Topical Application to Experimentally Induced Skin Cancer in Mice}, author={Mousa IA and Hammady TM and Gad S and Zaitone SA and El-Sherbiny M and Sayed OM}, journal={Pharmaceuticals (Basel)}, volume={15}, number={6}}"}}, {"_id": "39630677", "pmid": 39630677, "title": "Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study.", "journal": "J Drugs Dermatol", "authors": ["Haq Z", "Mirza FN", "Abdi P", "Diaz MJ", "Libby TJ"], "date": "2024-12-01T00:00:00Z", "doi": "10.36849/jdd.8249", "meta_date_publication": "2024 Dec 1", "meta_volume": "23", "meta_issue": "12", "meta_pages": "1089-1095", "score": 50264.133, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use and Risk of @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@Non-Melanoma Skin Cancer@@@: A Propensity-Matched Case-Control Study.", "citations": {"NLM": "Haq Z, Mirza FN, Abdi P, Diaz MJ, Libby TJ. Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study. J Drugs Dermatol. 2024 Dec 1;23(12):1089-1095. PMID: 39630677", "BibTeX": "@article{39630677, title={Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study.}, author={Haq Z and Mirza FN and Abdi P and Diaz MJ and Libby TJ}, journal={J Drugs Dermatol}, volume={23}, number={12}, pages={1089-1095}}"}}, {"_id": "32958585", "pmid": 32958585, "title": "Risk of Skin Cancer Associated with Metformin Use: A Meta-Analysis of Randomized Controlled Trials and Observational Studies.", "journal": "Cancer Prev Res (Phila)", "authors": ["Chang MS", "Hartman RI", "Xue J", "Giovannucci EL", "Nan H", "Yang K"], "date": "2021-01-01T00:00:00Z", "doi": "10.1158/1940-6207.CAPR-20-0376", "meta_date_publication": "2021 Jan", "meta_volume": "14", "meta_issue": "1", "meta_pages": "77-84", "score": 50262.26, "text_hl": "Risk of @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@Skin Cancer@@@ Associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use: A Meta-Analysis of Randomized Controlled Trials and Observational Studies.", "citations": {"NLM": "Chang MS, Hartman RI, Xue J, Giovannucci EL, Nan H, Yang K. Risk of Skin Cancer Associated with Metformin Use: A Meta-Analysis of Randomized Controlled Trials and Observational Studies. Cancer Prev Res (Phila). 2021 Jan;14(1):77-84. PMID: 32958585", "BibTeX": "@article{32958585, title={Risk of Skin Cancer Associated with Metformin Use: A Meta-Analysis of Randomized Controlled Trials and Observational Studies.}, author={Chang MS and Hartman RI and Xue J and Giovannucci EL and Nan H and Yang K}, journal={Cancer Prev Res (Phila)}, volume={14}, number={1}, pages={77-84}}"}}, {"_id": "37863201", "pmid": 37863201, "title": "Analysis of Metformin, Niacinamide, and Niacin as Skin Cancer Preventative Medications in Solid Organ Transplant Recipients.", "journal": "J Am Acad Dermatol", "authors": ["Linkous C", "Strat N", "Shope C", "Andrews L", "Lee LW"], "date": "2023-10-18T00:00:00Z", "doi": "10.1016/j.jaad.2023.10.023", "meta_date_publication": "2023 Oct 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50257.46, "text_hl": "Analysis of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Niacinamide @CHEMICAL_MESH:D009536 @@@Niacinamide@@@, and @CHEMICAL_Niacin @CHEMICAL_MESH:D009525 @@@Niacin@@@ as @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@Skin Cancer@@@ Preventative Medications in Solid Organ Transplant Recipients.", "citations": {"NLM": "Linkous C, Strat N, Shope C, Andrews L, Lee LW. Analysis of Metformin, Niacinamide, and Niacin as Skin Cancer Preventative Medications in Solid Organ Transplant Recipients. J Am Acad Dermatol. 2023 Oct 18;():. PMID: 37863201", "BibTeX": "@article{37863201, title={Analysis of Metformin, Niacinamide, and Niacin as Skin Cancer Preventative Medications in Solid Organ Transplant Recipients.}, author={Linkous C and Strat N and Shope C and Andrews L and Lee LW}, journal={J Am Acad Dermatol}}"}}, {"_id": "39974652", "pmid": 39974652, "title": "Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.", "journal": "ACS Pharmacol Transl Sci", "authors": ["Martins M", "Veiga F", "Paiva-Santos AC", "Pires PC"], "date": "2025-01-23T00:00:00Z", "doi": "10.1021/acsptsci.4c00679", "meta_date_publication": "2025 Feb 14", "meta_volume": "8", "meta_issue": "2", "meta_pages": "308-338", "score": 50250.34, "text_hl": "Drug Repurposing and Nanotechnology for Topical @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@Skin Cancer@@@ Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.", "citations": {"NLM": "Martins M, Veiga F, Paiva-Santos AC, Pires PC. Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects. ACS Pharmacol Transl Sci. 2025 Feb 14;8(2):308-338. PMID: 39974652", "BibTeX": "@article{39974652, title={Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.}, author={Martins M and Veiga F and Paiva-Santos AC and Pires PC}, journal={ACS Pharmacol Transl Sci}, volume={8}, number={2}, pages={308-338}}"}}, {"_id": "36642349", "pmid": 36642349, "title": "Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: Thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity.", "journal": "Int J Pharm", "authors": ["Donadon LGF", "Salata GC", "Gonçalves TP", "Matos LC", "Evangelista MCP", "da Silva NS", "Martins TS", "Machado-Neto JA", "Lopes LB", "Garcia MTJ"], "date": "2023-02-25T00:00:00Z", "doi": "10.1016/j.ijpharm.2023.122612", "meta_date_publication": "2023 Feb 25", "meta_volume": "633", "meta_issue": "", "meta_pages": "122612", "score": 50244.074, "text_hl": "This study evaluated the potential of @CHEMICAL_monoolein @CHEMICAL_MESH:C005953 @@@monoolein@@@ (MO)-based nanodispersions to promote the cutaneous co-delivery of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@) and @CHEMICAL_Methylene_Blue @CHEMICAL_MESH:D008751 @@@methylene blue@@@ (@CHEMICAL_Methylene_Blue @CHEMICAL_MESH:D008751 @@@MB@@@) for the treatment of @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@non-melanoma skin cancer@@@. ", "citations": {"NLM": "Donadon LGF, Salata GC, Gonçalves TP, Matos LC, Evangelista MCP, da Silva NS, Martins TS, Machado-Neto JA, Lopes LB, Garcia MTJ. Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: Thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity. Int J Pharm. 2023 Feb 25;633():122612. PMID: 36642349", "BibTeX": "@article{36642349, title={Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: Thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity.}, author={Donadon LGF and Salata GC and Gonçalves TP and Matos LC and Evangelista MCP and da Silva NS and Martins TS and Machado-Neto JA and Lopes LB and Garcia MTJ}, journal={Int J Pharm}, volume={633}, pages={122612}}"}}, {"_id": "37313551", "pmid": 37313551, "pmcid": "PMC10260318", "title": "Hyaluronic Acid-Coated Chitosan/Gelatin Nanoparticles as a New Strategy for Topical Delivery of Metformin in Melanoma", "journal": "Biomed Res Int", "authors": ["Ebrahimnejad P", "Rezaeiroshan A", "Babaei A", "Khanali A", "Aghajanshakeri S", "Farmoudeh A", "Nokhodchi A"], "date": "2023-06-05T00:00:00Z", "doi": "10.1155/2023/3304105", "meta_date_publication": "2023", "meta_volume": "2023", "meta_issue": "", "meta_pages": "3304105", "score": 50243.938, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is a multipotential compound for treating @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@diabetes II@@@ and controlling hormonal @DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@acne@@@ and @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@skin cancer@@@. ", "citations": {"NLM": "Ebrahimnejad P, Rezaeiroshan A, Babaei A, Khanali A, Aghajanshakeri S, Farmoudeh A, Nokhodchi A. Hyaluronic Acid-Coated Chitosan/Gelatin Nanoparticles as a New Strategy for Topical Delivery of Metformin in Melanoma Biomed Res Int. 2023;2023():3304105. PMID: 37313551", "BibTeX": "@article{37313551, title={Hyaluronic Acid-Coated Chitosan/Gelatin Nanoparticles as a New Strategy for Topical Delivery of Metformin in Melanoma}, author={Ebrahimnejad P and Rezaeiroshan A and Babaei A and Khanali A and Aghajanshakeri S and Farmoudeh A and Nokhodchi A}, journal={Biomed Res Int}, volume={2023}, pages={3304105}}"}}, {"_id": "38609130", "pmid": 38609130, "title": "EDUCATION FROM DERMATOLOGISTS: THE SIMULTANEOUSLY DEVELOPMENT OF 16 KERATINOCYTIC CANCERS AFTER USE OF METFORMIN IN COMBINATION WITH LOSARTAN/ HYDROCHLOROTHIAZIDE, METOPROLOL AND NIFEDIPINE- IMPORTANT LINKS TO DRUG RELATED (PHOTO)-NITROSO-CARCINOGENESIS AND ONCOPHARMACOGENESIS.", "journal": "Georgian Med News", "authors": ["Tchernev G", "Dimova D"], "date": "2024-02-01T00:00:00Z", "meta_date_publication": "2024 Feb", "meta_volume": "", "meta_issue": "347", "meta_pages": "136-141", "score": 50236.312, "text_hl": "According to recent FDA data, the concentration of NDMA in just one @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ tablet could be up to more than 5-fold increased. ", "citations": {"NLM": "Tchernev G, Dimova D. EDUCATION FROM DERMATOLOGISTS: THE SIMULTANEOUSLY DEVELOPMENT OF 16 KERATINOCYTIC CANCERS AFTER USE OF METFORMIN IN COMBINATION WITH LOSARTAN/ HYDROCHLOROTHIAZIDE, METOPROLOL AND NIFEDIPINE- IMPORTANT LINKS TO DRUG RELATED (PHOTO)-NITROSO-CARCINOGENESIS AND ONCOPHARMACOGENESIS. Georgian Med News. 2024 Feb;(347):136-141. PMID: 38609130", "BibTeX": "@article{38609130, title={EDUCATION FROM DERMATOLOGISTS: THE SIMULTANEOUSLY DEVELOPMENT OF 16 KERATINOCYTIC CANCERS AFTER USE OF METFORMIN IN COMBINATION WITH LOSARTAN/ HYDROCHLOROTHIAZIDE, METOPROLOL AND NIFEDIPINE- IMPORTANT LINKS TO DRUG RELATED (PHOTO)-NITROSO-CARCINOGENESIS AND ONCOPHARMACOGENESIS.}, author={Tchernev G and Dimova D}, journal={Georgian Med News}, number={347}, pages={136-141}}"}}, {"_id": "23437788", "pmid": 23437788, "title": "Metformin in dermatology: an overview.", "journal": "J Eur Acad Dermatol Venereol", "authors": ["Badr D", "Kurban M", "Abbas O"], "date": "2013-11-01T00:00:00Z", "doi": "10.1111/jdv.12116", "meta_date_publication": "2013 Nov", "meta_volume": "27", "meta_issue": "11", "meta_pages": "1329-35", "score": 50063.047, "text_hl": "This is an evidence-based review on the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment of @DISEASE_Skin_Diseases @DISEASE_MESH:D012871 @@@skin disorders@@@ such as @DISEASE_Hirsutism @DISEASE_MESH:D006628 @@@hirsutism@@@, @DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@acne@@@, @DISEASE_Hidradenitis_Suppurativa @DISEASE_MESH:D017497 @@@hidradenitis suppurativa@@@, @DISEASE_Acanthosis_Nigricans @DISEASE_MESH:D000052 @@@acanthosis nigricans@@@, @DISEASE_Psoriasis @DISEASE_MESH:D011565 @@@psoriasis@@@, @<m>DISEASE_Skin_Neoplasms</m> @DISEASE_MESH:D012878 @@@skin cancer@@@, among others. ", "citations": {"NLM": "Badr D, Kurban M, Abbas O. Metformin in dermatology: an overview. J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1329-35. PMID: 23437788", "BibTeX": "@article{23437788, title={Metformin in dermatology: an overview.}, author={Badr D and Kurban M and Abbas O}, journal={J Eur Acad Dermatol Venereol}, volume={27}, number={11}, pages={1329-35}}"}}]}